Effect of metformin on mortality in patients with heart failure and type 2 diabetes mellitus

American Journal of Cardiology

Volumn 106, Issue 7, 2010, Pages 1006-1010

  Evans, Josie M M ^a   Doney, Alex S F ^b   Alzadjali, Matlooba A ^b   Ogston, Simon A ^c   Petrie, John R ^c   Morris, Andrew D ^c   Struthers, Allan D ^b   Wong, Aaron K F ^b   Lang, Chim C ^b  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; TREATMENT OUTCOME;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; TREATMENT OUTCOME;

EID: 77956971910     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.05.031     Document Type: Article

References (23)

1. A.K. Wong, M.A. AlZadjali, A.M. Choy, and C.C. Lang Insulin resistance: a potential new target for therapy in patients with heart failure Cardiovasc Ther 26 2008 203 213
2. F.A. Masoudi, S.E. Inzucchi, Y. Wang, E.P. Havranek, J.M. Foody, and H.M. Krumholz Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 2005 583 590
3. J.A. Johnson, S.R. Majumdar, S.H. Simpson, and E.L. Toth Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes Diabetes Care 25 2002 2244 2248
4. A. Holstein, and M. Stumvoll Contraindications can damage your healthis metformin a case in point? Diabetologia 48 2005 2454 2459
5. S.E. Inzucchi Metformin and heart failure: innocent until proven guilty Diabetes Care 28 2005 2585 2587
6. J. McCormack, K. Johns, and H. Tildesley Metformin's contraindications should be contraindicated CMAJ 173 2005 502 504
7. J.M. Evans, S.A. Ogston, A. Emslie-Smith, and A.D. Morris Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin Diabetologia 49 2006 930 936
8. A.D. Morris, D.I. Boyle, R. MacAlpine, A. Emslie-Smith, R.T. Jung, R.W. Newton, and T.M. MacDonald The Diabetes Audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register DARTS/MEMO Collaboration BMJ 315 1997 524 528
9. A.D. Struthers, P.T. Donnan, P. Lindsay, D. McNaughton, J. Broomhall, and T.M. MacDonald Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study Heart 87 2002 229 234
10. C.J. Bailey, and R.C. Turner Metformin N Engl J Med 334 1996 574 579
11. A.J. Coats, and S.D. Anker Insulin resistance in chronic heart failure J Cardiovasc Pharmacol 35 suppl 2000 S9 S14
12. J.W. Swan, S.D. Anker, C. Walton, I.F. Godsland, A.L. Clark, F. Leyva, J.C. Stevenson, and A.J. Coats Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
13. N. Suskin, R.S. McKelvie, R.J. Burns, R. Latini, D. Pericak, J. Probstfield, J.L. Rouleau, C. Gigouin, C.B. Solymoss, R. Tsuyuki, M. White, and S. Yufuf Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur Heart J 21 2000 1368 1375
14. M.A. AlZadjali, V. Godfrey, F. Khan, A. Choy, A.S. Doney, A.K. Wong, J.R. Petrie, A.D. Struthers, and C.C. Lang Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure J Am Coll Cardiol 53 2009 747 753
15. W. Doehner, M. Rauchhaus, P. Ponikowski, I.F. Godsland, S. von Haehling, D.O. Okonko, F. Leyva, A.J. Proudler, A.J. Coats, and S.D. Anker Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure J Am Coll Cardiol 46 2005 1019 1026
16. D. Kirpichnikov, S.I. McFarlane, and J.R. Sowers Metformin: an update Ann Intern Med 137 2002 25 33
17. R.A. DeFronzo, and A.M. Goodman Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus The Multicenter Metformin Study Group N Engl J Med 333 1995 541 549
18. I. Tzoulaki, M. Molokhia, V. Curcin, M.P. Litle, C.J. Millett, A. Ng, R.I. Hughes, K. Khunti, M.R. Wilkins, A. Majeed, and P. Elliott Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database BMJ 339 2009 b4731
19. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
20. J.A. Johnson, S.R. Majmudar, and S.H. Simpson Decreased mortality associated with metformin use compared to sulfonylurea monotherapy in type 2 diabetes mellitus Diabetes Care 25 2004 2244 2248
21. A.K. Wong, J. Howie, J.R. Petrie, and C.C. Lang AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease Clin Sci (Lond) 116 2009 607 620
22. R.R. Russell III, J. Li, D.L. Coven, M. Pypaert, C. Zechner, M. Palmeri, F.J. Giordano, J. Mu, M.J. Birnbaum, and L.H. Young AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J Clin Invest 114 2004 495 503
23. K.J. Mather, S. Verma, and T.J. Anderson Improved endothelial function with metformin in type 2 diabetes mellitus J Am Coll Cardiol 37 2001 1344 1350